JG
ARIA

Jefferies Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Jefferies Group’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-114,400
Closed -$668K – 2752
2015
Q3 		$668K Buy
+114,400
New +$881K ﹤0.01% 1377
2015
Q2 		– Sell
-100,000
Closed -$824K – 3623
2015
Q1 		$824K Sell
100,000
-7,600
-7% -$56.2K ﹤0.01% 1146
2014
Q4 		$739K Sell
107,600
-37,800
-26% -$236K ﹤0.01% 1102
2014
Q3 		$785K Buy
145,400
+76,600
+111% +$447K 0.01% 1115
2014
Q2 		$438K Sell
68,800
-83,500
-55% -$574K ﹤0.01% 1308
2014
Q1 		$1.23M Sell
152,300
-198,800
-57% -$1.55M 0.01% 834
2013
Q4 		$2.4M Buy
351,100
+256,100
+270% +$1.38M 0.02% 520
2013
Q3 		$1.75M Buy
95,000
+55,000
+138% +$1.07M 0.02% 658
2013
Q2 		$700K Buy
+40,000
New +$709K 0.01% 927

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jefferies Group's ARIA Position: Q4 2015 in Review

Jefferies Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2015, closing a stake of 64,762 shares — an estimated $379K sold.

Jefferies Group first reported a position in ARIA in Q2 2013 and held it in 10 quarters. The position peaked at $2.13M in Q1 2015. 172 funds tracked by Wall St. Rank hold ARIA as of Q4 2015.

  • Jefferies Group reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Jefferies Group sold 64,762 Ariad Pharmaceuticals Inc shares in Q4 2015, an estimated $379K.
  • Jefferies Group first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 10 quarters.
  • Jefferies Group's Ariad Pharmaceuticals Inc position peaked at $2.13M in Q1 2015.
  • 172 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2015.

Based on Jefferies Group's 13F filing for Q4 2015, filed 12 Feb 2016.